InsidersTradesSigma
Track the Burning Rock Biotech Ltd stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €180.4m. The latest transaction was filed on 2 April 2026 (Acquisition). Among the most active insiders: Han Yusheng. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Burning Rock Biotech Ltd is a company focused on developing molecular diagnostic solutions for cancer. It is listed on NASDAQ under the ticker BNR.